Bruker Corp

NASDAQ:BRKRUnited States

May 7, 2024

Show headlines and story abstract

• Bruker's NanoString Secures Patent Case Win in Germany, from 2:45PM ET on Tuesday May 07, 2024 by MT Newswires

  2:45PM ET on Tuesday May 07, 2024 by MT Newswires
  Companies Mentioned: TXG, BRKR
  02:45 PM EDT, 05/07/2024 (MT Newswires) -- Bruker (BRKR) said Tuesday that the German Federal Patent Court has ruled in favor of its unit, NanoString Technologies Germany, by invalidating 10x Genomics' (TXG) European patent No. 2794928B1 in Germany....

• German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker, from 2:04PM ET on Tuesday May 07, 2024 by Dow Jones

  2:04PM ET on Tuesday May 07, 2024 by Dow Jones
  Companies Mentioned: BRKR
  
  NanoString, now a Bruker business, will promptly seek an end to the injunction impacting sales of CosMx SMI products in Germany
  BILLERICA, Mass.--(BUSINESS WIRE)--May 07, 2024--
  

• German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker, from 2:04PM ET on Tuesday May 07, 2024 by Business Wire

  2:04PM ET on Tuesday May 07, 2024 by Business Wire
  Companies Mentioned: BRKR

  Bruker Corporation (Nasdaq: BRKR) today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No. 2794928B1 (the "928 Patent") in Germany (case 3 Ni 20/22). NanoString is now a Bruker business following Bruker's asset acquisition of the businesses of NanoString Technologies, Inc on May 6th, 2024. The 928 Patent has been asserted by 10x Genomics against NanoString in patent infringement cases in Germany and before the European Unified Patent Court (UPC) involving NanoString's CosMx Spatial Molecular Imager (SMI) products for RNA detection. The Federal Patent Court ruled that the German part of the 928 Patent is invalid.